🔎 Trials Near Me

Akèy › Glomeruloskleroz fokal segmantè › Illinois

Etid klinik pou Glomeruloskleroz fokal segmantè nan Illinois

4 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan Illinois.

Vil nan Illinois

Tèks ofisyèl etid la (Anglè)

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • Northwestern University, Chicago
  • Endeavor Health, Evanston
  • ak 1 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07220083

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  • Northwestern Memorial Hospital- Site Number : 8400014, Chicago
  • Nephrology Associates of Northern Illinois and Indiana (NANI) - Hinsdale- Site Number : 8400017, Hinsdale
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702

NEPTUNE Match Study

  • John H. Stroger, Jr., Hospital of Cook County, Chicago
Ap rekrite
Laj 1 a 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT04571658

Nephrotic Syndrome Study Network

  • John Stroger Cook County Hospital, Chicago
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.